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Abstract
Background: Several clinical and experimental studies have shown that unnecessary right 
ventricular pacing in sinus node disease can be detrimental. Inter- and intra-ventricular asyn-
chrony imposed by right ventricular pacing may cause reduction in contractility and relaxation 
of left ventricle, worsening mitral regurgitation, regional redistribution of myocardial perfu-
sion and oxygen consumption, and asymmetrical hypertrophy of left ventricular wall. In some 
patients, sinus node disease coexists with impaired atrioventricular conduction. The optimal 
pacing mode in this population is not determined. Minimizing right ventricular pacing can 
preserve inter- and intra-ventricular synchrony. On the other hand, longer atrioventricular 
delay may cause atrioventricular asynchrony. The aim of this study was to prospectively assess 
the impact of minimizing right ventricular pacing in patients with DDD pacemaker implanted 
for sinus node disease and prolonged PQ interval on exercise capacity, cardiac function and 
quality of life.
Methods: The study enrolled 50 consecutive patients with prolonged PQ interval who were 
implanted with DDD pacemaker because of sinus node disease. Each patient was treated alter-
nately with 2 pacing modes in random order for 4-month periods: conventional dual-chamber 
pacing and dual-chamber minimal ventricular pacing (prolonged atrioventricular delay). At 
the end of each phase the following tests were performed: cardiopulmonary exercise testing, 
echocardiographic evaluation and quality of life assessment (SF36).
Results: There was no significant relationship between pacing mode and cardiopulmonary 
parameters, echocardiographic parameters and quality of life.
Conclusions: Sequential atrioventricular pacing may be a reasonable choice for treating 
patients with sinus node disease and prolonged PQ interval. (Cardiol J 2015; 22, 1: 75–79)
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Introduction
Several clinical and experimental studies have 
shown that unnecessary right ventricular pacing 
(RVP) in sinus node disease (SND) can be detri-
mental. Inter- and intra-ventricular asynchrony 
imposed by RVP may cause reduction in contracti-
lity and relaxation of left ventricle (LV), worsening 
mitral regurgitation, regional redistribution of 
myocardial perfusion and oxygen consumption, 
and asymmetrical hypertrophy of the LV wall [1–7].
In 23–58% of patients with SND, atrioventri-
cular (AV) conduction is also impaired. Two thirds 
of these patients have first degree AV block [8, 9]. 
Prolonged AV conduction may lead to diastolic 
mitral regurgitation and in some patients may 
decrease exercise capacity [10, 11].
The optimal pacing mode in patients with 
SND and concomitant first degree AV block is not 
determined. Minimizing RVP can preserve inter- 
and intra-ventricular synchrony. On the other hand, 
longer AV delay may cause AV asynchrony. The 
purpose of the present study was to assess the 
impact of minimizing RVP on exercise capacity, 
cardiac function and quality of life.
Methods
The study was approved by the Institutional 
Review Board of the Military Institute of Medici-
ne (IRB followed the Helsinki recommendations, 
approval number 32/WIM/2008). All of the subjects 
provided informed consent.
We prospectively assessed patients that had 
had an implantation of DDD pacemaker in our 
hospital due to SND. The inclusion criteria were: 
(1) PQ interval ≥ 200 ms at baseline; (2) the per-
centage of RVP ≥ 90% during the 1st week after the 
procedure (with default AV delay). Patients were 
excluded if they had second or third degree AV 
block or severely impaired LV systolic function (LV 
ejection fraction [LVEF] ≤ 35%). Patients eligible 
for the study were included on the 7th day after 
implantation. The study had a crossover design. 
Every patient was observed for 2 consecutive 
periods lasting 3–5 months. In the 1st of the study 
periods standard AV delay was set. In the other, AV 
delay was prolonged to achieve minimized ventri-
cular pacing. The order of these time periods was 
randomized. After the completion of the 1st period 
every subject was treated with the opposite AV 
delay settings for approximately the same time. At 
the end of each study period the following data was 
acquired: (1) percentage of ventricular and atrial 
pacing (extracted from the pacemaker storage); 
(2) exercise capacity assessed by cardiopulmona-
ry exercise testing (CPET); (3) LV and left atrial 
dimensions and LVEF determined by echocardio-
graphy; (4) quality of life assessed by short form 
36 questionnaire (SF36). A paired approach was 
adopted in the analysis of the data.
Pacemaker settings
The exact AV delay settings were individu-
alized and dependent on a model of pacemaker, 
baseline PQ interval, and upper tracking rate. 
The maximal AV delay (for the lower rate) in the 
standard period was 180 ms, minimal: 170 ms 
(177 ms on average). In the minimized RVP period the 
numbers were 350 ms and 250 ms, respectively 
(301 ms on average). Automatic shortening of the 
AV delay was allowed during rate increases. The 
lower rate during the diurnal and nocturnal hours 
was set at 60 bpm and 50–55 bpm, respectively. The 
upper rate was set according to age and general 
condition of each patient. In the case of chronotro-
pic incompetence, the rate response features were 
adopted. The above mentioned settings, except for 
the AV delays, were not changed during the whole 
study period.
Cardiopulmonary exercise testing
Symptom-limited CPET was performed on 
a cycle or treadmill ergometer with a protocol 
that was personalized with the aim of having each 
patient reach maximum exercise in 7–10 min. 
The protocol was the same for both study arms. 
Breath-by-breath measurements of gas exchange 
were obtained by a metabolic cart (ZAN 680; ZAN 
Messgerate GmbH; Germany). Minute ventilation 
(VE), oxygen uptake and carbon dioxide output 
(VCO2) were averaged over 10 s. Peak oxygen 
uptake (VO2) was expressed as the mean value of 
VO2 during the last 30 s of the exercise test. Ven-
tilatory anaerobic threshold (VAT) was detected by 
the V-slope method. VE/VCO2 slope was calculated 
as a linear regression function using the data points 
from the whole exercise period. Peak oxygen pulse 
(O2 pulse) was delineated as peak VO2 divided by 
peak heart rate.
Echocardiography
All patients underwent comprehensive 
transthoracic echocardiography examination by 
system Vivid 7 GE. End-systolic and end-diastolic 
volumes, and ejection fraction were calculated by 
modified biplane Simpson’s method.
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Statistical analysis
Continuous data are expressed as mean ± 
± standard deviation. A Student’s paired t-test or 
Wilcoxon signed rank test in case of non-normally 
distributed data were used for repeated measures. 
For qualitative variables the Fisher’s exact test was 
employed. Statistical differences with a p value < 0.05 
were considered significant. All calculations were 
performed with statistical software (SAS 9.3; 
SAS Institute Inc.; Cary, NC, USA).
Results
From June 2008 to December 2011 we enrolled 
50 patients on the study. The study flow diagram 
is presented in Figure 1. The demographic and cli-
nical data for 44 patients used in the final analysis 
are summarized in Table 1.
The mean duration of pacing with standard 
AV delay and of minimized ventricular pacing was 
124 ± 33 days and 121 ± 33 days, respectively 
(p = 0.81). During the minimized ventricular pac-
ing period the percentage of RVP was reduced 
to a median of 16% in comparison to 98% during 
standard pacing (p < 0.0001). The QRS duration 
Table 1. Baseline characteristics of the patients.
Age [years] 75 ± 7
Male gender 28 (64%)
History of paroxysmal AF 19 (43%)
Coronary artery disease 17 (39%)
Arterial hypertension 33 (75%)
PQ interval [ms] 234 ± 26
QRS duration [ms] 109 ± 18
LV ejection fraction [%] 60 ± 6
LV diastolic diameter [cm] 4.8 ± 0.5
RVOT position of ventricular lead 42 (96%)
Percentage of ventricular pacing  
during the first week after  
implantation [%]
97.2 ± 2.7
Medication:
Beta-blocker 21 (48%)
ACE inhibitors 31 (71%)
ARB 7 (16%)
Antiarrhythmics (amiodarone, 
propafenone)
9 (21%)
Calcium-channel blockers 11 (25%)
Diuretics 21 (48%) 
ACE — angiotensin-converting enzyme; ARB — angiotensin  
receptor blockers; AF — atrial fibrillation; LV — left ventricular;  
RVOT — right ventricle outflow tract
Figure 1. Flow diagram: screening, exclusion, randomization and follow-up of patients; AF — atrial fibrillation; 
CPET — cardiopulmonary exercise testing; ECHO — echocardiography; SF36 — short form 36 questionnaire.
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was also diminished: 113 ± 26 vs. 155 ± 20 ms, 
respectively (p < 0.0001). However, a quarter of 
patients still had more than 40% of RVP during 
minimized ventricular pacing. There were no sig-
nificant differences between the study periods in 
percentage of atrial pacing (p = 0.38).
The peak oxygen uptake, ventilatory anaerobic 
threshold, VE/VCO2 slope, LV diastolic diameter, 
left atrial diameter and LVEF did not differ accor-
ding to the pacing mode (Table 2). When comparing 
the results of 8 subscales of the SF36 questionnai-
re, they did not reveal any significant differences 
between the study groups (Table 3).
Discussion
The present study compared minimized RVP 
with standard settings of AV delay in a selected 
group of patients with both SND and first degree 
AV block. The result was that no significant im-
provement in exercise capacity and quality of life 
was associated with a reduced percentage of RVP. 
These findings suggest that sequential AV pacing 
with standard AV settings may be a reasonable 
choice in this group of patients.
Several laboratory and clinical studies have 
shown that RVP may result in reduced LV systolic 
and diastolic function [6, 7, 12]. Due to ventricular 
desynchronization ventricular pacing may promote 
heart failure. The risk of developing heart failure 
grows with increasing cumulative percentage of 
RVP [13–15]. However, reducing ventricular pacing 
by extending AV delay may lead to AV desynchro-
nization. Prolonged PQ interval or stimulus-R 
interval in atrial pacing may result in diastolic 
mitral regurgitation, and in consequence in heart 
failure [10, 11, 16]. Thus, the LV performance de-
pends on both intra-ventricular and AV synchrony. 
Prolonged AV conduction in all patients included 
in the present study may explain why minimizing 
ventricular pacing had no impact on exercise ca-
pacity and cardiac function.
Similar observations were presented by Var-
das et al. [17] in 15 patients with SND and normal 
AV conduction. They reported no difference in 
the anaerobic threshold according to the pacing 
mode: AAI or DDD with short AV delay [17]. The 
possible reason for this result may be that AV 
conduction during atrial pacing in patients with 
SND may paradoxically lengthen with increasing 
Table 3. Quality of life.
Subscales of SF36 questionnaire AV sequential pacing  
with standard AV delay
Minimized ventricular 
pacing
P 
Physical functioning 63.5 ± 18.8 62.4 ± 22.5 0.48*
Physical role functioning 49.4 ± 26.7 45.9 ± 27.5 0.27†
Bodily pain 60.8 ± 24.0 61.9 ± 25.1 0.82*
General health perceptions 50.6 ± 13.2 47.3 ± 13.9 0.052*
Vitality 52.8 ± 18.3 49.6 ± 16.7 0.17*
Social role functioning 70.3 ± 24.0 64.8 ± 22.7 0.053*
Emotional role functioning 62.4 ± 27.5 61.2 ± 28.1 0.72*
Mental health 64.2 ± 18.4 63.6 ± 17.2 0.78†
*Wilcoxon signed-rank test; †paired Student’s t-test; AV — atrioventricular
Table 2. Cardiopulmonary exercise testing and echocardiographic variables.
Variable AV sequential pacing  
with standard AV delay
Minimized ventricular 
pacing
P 
Peak oxygen consumption [mL/kg/min] 17.1 ± 5.9 16.6 ± 5.3 0.26†
Anaerobic threshold [mL/kg/min] 12.3 ± 5.0 12.3 ± 4.2 0.36*
VE/VCO2 slope 29.2 ± 4.6 30.1 ± 8.1 0.69*
Left ventricular diastolic diameter [cm] 5.0 ± 0.6 5.0 ± 0.6 0.64†
Left atrium diameter [cm] 4.34 ± 0.47 4.21 ± 0.55 0.12†
Left ventricular ejection fraction [%] 59.3 ± 9.6 59.2 ± 12.1 0.99†
*Wilcoxon signed-rank test; †paired Student’s t-test; AV — atrioventricular
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pacing rate during exercise [18, 19]. This lack of 
physiological adaptation of the AV interval when 
exercising may be the result of the maladjustment 
of the adrenergic tone to the heart rate determined 
by the pacemaker [18].
In contrast to our findings, Wonisch et al. [20] 
reported improvement in CPET variables with 
pacing modes that minimize ventricular pacing in 
17 patients with heart failure and cardioverter-
-defibrillator. The possible explanation of these 
results may lie in the fact that RVP in hearts that 
are impaired at the baseline leads to a greater ex-
tending of intra-ventricular desynchronization. The 
QRS duration (QRSd) and LV activation time due 
to RVP are increased when LVEF is less than 40% 
in comparison to hearts with preserved LV systolic 
function: QRSd 209 ms vs. 193 ms, respectively and 
LV activation time 186 ms vs. 129 ms, respectively 
[21]. In our study, however, the LV function was 
not impaired at baseline with mean LVEF of 60% 
and QRSd of 109 ms. This may be the reason we 
did not observe any deleterious effects of RVP.
Limitations of the study
There are several limitations of the present 
study. Small number of patients included, short 
follow-up period in each pacing mode, and resi-
dual ventricular pacing over 40% in a quarter of 
patients could have mitigated the possible benefit 
of minimized ventricular pacing.
Conclusions
The results of the present study support the 
view that sequential AV pacing in SND patients 
with prolonged PQ interval is a safe alternative 
regarding exercise capacity, cardiac function and 
quality of life. However, the study group was too 
small and the follow-up period too short to assess 
the impact of minimizing ventricular pacing on 
mortality and heart failure development.
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